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Carotid Stent-Supported Angioplasty Using Different Distal Protection
Devices
STEVEN SIU-LUNG LI, YUI-CHI SO, CHIU-LAI FU, CHEUK-HON WONG, CHIU-WAH LAM, SIU-FUNG
YIU, CHUNG-SEUNG CHIANG, KAU-CHUNG HO
From Division of Cardiology, Department of Medicine, Queen Elizabeth Hospital, Kowloon, Hong Kong
LI ET AL.: Carotid Stent-Supported Angioplasty Using Different Distal Protection Devices. Stroke is an important
cause of morbidity and mortality in Hong Kong. Extra-cranial carotid stenosis is a common cause of thrombotic
stroke, although its incidence is less in Chinese compared with Caucasians. Carotid endarterectomy is the conventional
revascularization procedure for carotid stenosis. In the past decade, carotid angioplasty has been emerging as a
treatment option for patients with significant carotid stenosis. Due to the intrinsic mechanism of angioplasty, distal
embolization causing thromboembolic stroke has been one of the most important complications of carotid stenosis.
Distal protection has been shown to be safe and effective in preventing distal embolization during the procedure.
According to their mechanism, distal protection devices can be categorized into two major types, namely distal
occlusion balloon and filters. Distal occlusion balloon system is of lower crossing profile but it causes temporary
cessation of blood flow during the procedure, which may not be well tolerated in all patients. Filters, on the other
hand, allow continuous blood flow during the procedure but are of much higher crossing profile, which may make
their passage through tight and angulated lesions difficult and traumatic. The choice of the different distal protection
devices depends on the characteristics of the lesions and the status of contralateral carotid artery and collateral
supply. Local experience reported similar feasibility and efficacy as in the literature. Although the ideal distal
protection device is yet to be developed, the use of distal protection devices would become, wherever feasible, a
standard during carotid stent-supported angioplasty. (J HK Coll Cardiol 2002;10:179-183)
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Stroke is an important cause of morbidity and
mortality in Hong Kong. Extra-cranial carotid stenosis
is a common cause of thrombotic stroke. The therapy
of carotid stenosis may be either medical or
revascularizational. Carotid endarterectomy is the gold
standard of surgical revascularization of carotid stenosis
and has been shown to be superior to medical therapy
by several large randomized trials.1-3 However, in the
recent few years, with more and more published data
regarding its efficacy and safety, carotid stenosis has
been emerging as a treatment option for the treatment
of carotid stenosis.4-7
Due to the intrinsic mechanism of angioplasty,
distal embolization is an inevitable phenomenon. Plaque
disruption may occur during engagement of guiding
catheter, wire and balloon passage, balloon expansion
and stent deployment at the site of atherosclerotic lesion.
The clinical significance of the generation of embolic
particles depends on the number released and the size
of the particles. Ohki demonstrated in his ex-vivo model
that echolucent plaques and plaques with a degree of
stenosis greater than 90% produced a higher number of
embolic particles.8
There may be a number of ways to minimize the
cerebral embolization during carotid angioplasty.
Premedication with aspirin and Clopidogrel is
important. Selection of patients is also important.
Advanced age, lesion severity, long or multiple stenoses
are independent predictors of procedural stroke and are
associated with increased risk of stroke. 9 Proper
technique during the angioplasty procedure with the
least traumatic way to engage the guiding catheter and
to cross the lesion with low profile wires and balloons
should minimize the risks of distal embolization.
Finally, cerebral distal protection devices should
mechanically catch the maximal number of embolic
particles released.

The ideal protection device should be simple and
easy to use, and yet low profile and atraumatic. It should
effectively eliminate embolic particles and be well
tolerated without any cerebral ischemic phenomenon.
The current commonly available distal protection
systems may be divided into two main categories,
namely the occlusion balloon system and filters. The
distal occlusion balloon system occludes the internal
carotid artery above the lesion with the balloon inflated
at 1-2 atmosphere. The debris released by the dilatation
and stent placement is then eliminated by aspiration.
Filters, on the other hand, trap dislodged particles
without interrupting the blood flow to the distal vascular
bed.
Currently, the occlusion balloon systems include
the PercuSurge Guardwire system (Medtronic, USA)
and the PARODI system (ArteriA Medical Science, Inc)
whereas the filters include the Angioguard (Cordis,
USA), NeuroShield (Mednova, UK) and EPI (Boston
Scientific Cooperation, USA) filter systems (Table 1).
The PercuSurge GuardWire distal protection
system (Figures 1a and 1b) composed of three major
components: the GuardWire temporary occlusion
balloon, the inflation/deflation kit (consisting of the
Microseal Adaptor and EZ Flator) and the Export
Aspiration Catheter. The GuardWire has a dual role by
acting as a primary angioplasty wire and the temporary
occlusion balloon. It has a crossing profile of 0.014" at
its tip and 0.036" at the site of un-inflated occlusion
balloon. The wire itself has a 2.5 cm shapeable tip and
a working length of 200 and 300 cm. The distal
occlusion balloon has a working length of 4.5 mm and
an inflatable diameter range of 3.0 to 6.0 mm. The
Export Aspiration catheter has a working length of 145
cm with a rapid exchange design and an aspiration
lumen of 1 mm.
During the intervention procedure, the Guardwire

Table 1. Comparison of different distal protection devices
Wire
Shapeable tip length (cm)
Length of wire(cm)
Crossing profile
Sizes of devices (mm)
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GuardWire Plus
0.014"
2.5
300
0.036" at balloon site
3.0-6.0 mm inflatable range

Angioguard XP
0.014"
3.5
300
3.2-3.9 F
4-8
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NeuroShield
0.014" with a 0.018" tip
3
300
3.5 F
4-6

EPI Filter Wire
0.014"
3
300
3.9 F
3.5-5.5
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is first advanced carefully beyond the lesion. The distal
occlusion balloon is then inflated to a size about 0.5
mm larger than the reference vessel diameter. When
the balloon is optimally inflated, it becomes square
shaped and complete occlusion is confirmed by a test
of contrast injection. With the occlusion balloon
inflated, the lesion is pre-dilated, stented and postdilated as usual. Due to the presence of vertebrae as
bony landmarks, positioning of the balloon and stent
without contrast injection is rarely a problem. Aspiration
is then performed with the Export catheter.
The occlusion balloon is then deflated and flow is
restored.
The PARODI system is a 'flow reversal' system.
It consists of two units: one is a small balloon catheter
that is used to occlude the external carotid artery; the
other is a large sheath that is used to occlude the
common carotid artery. Reverse flow is established by
connecting the arterial sheath with a venous sheath
placed into the femoral vein. Any debris generated
during the angioplasty procedure would be directed
away from the cerebral circulation. A filter located in
the arteriovenous shunt prevents embolic particles to
enter the venous system.
The filters in general consist of a basket or netshaped device mounted or delivered on a steerable
0.014" wire. The filters have a porous membrane that
can block the passage of particles greater than 80
microns or above, while allowing blood to pass through.

The device is delivered across the lesion within a
delivery sheath. For tight lesions, they may be first predilated with a 2.5 mm balloon. When positioned at the
desired distal site, the delivery sheath is withdrawn and
the filter is released in a self-expanding manner. The
angioplasty procedure is then proceeded as usual with
the filter protection. After the angioplasty procedure,
the filter is then withdrawn with a capture sheath with
all the debris retrieved within the device. Angioguard
XP (Figure 1c) has a crossing profile from 3.2 to 3.9 F
(depending on the size of the filter which ranges from
4-8 mm) and can be used to treat vessels of diameters
ranging from 3-7 mm. The filter basket with 100-micron
pores is mounted on a 0.014" wire, which has a 3.5 cm
shapeable tip. The Mednova III NeuroShield (Figure 1d)
device uses a floating filter on a bare wire design that
has a 3 cm long 0.018" shapeable wire tip and a 0.014"
wire shaft. The delivery catheter has a catheter profile
of 3 F and a crossing profile of 3.5 F. The filter diameters
range from 4.0 to 6.0 mm and are compatible for vessel
sizes of 3.5 to 6.2 mm diameters. The EPI Filter Wire
(Figure 1e) has a crossing profile of 3.9 F and has a
one-size-fits-all and monorail design that can treat
vessels from 3.5 to 5.5 mm. The filter consists of a 1.5
cm long polyurethane membrane basket with 80-100
micron pores, which is mounted on a 0.014" wire with
a 3 cm long shapeable tip.
Due to the different mechanism of protection, the
choice of the distal protection devices depends very

Figures 1a and 1b. GuardWire Plus system.
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Figure 1c. Angioguard XP.

Figure 1d. NeuroShield.

Figure 1e. EPI Filter Wire.
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much on the lesion characteristics, status of collateral
circulation and the experience of the operator. Due to
its smaller crossing profile, the PercuSurge Guardwire
system is useful in crossing tight, tortuous, long or
angulated lesions. However, since the mechanism of
protection involves temporary cessation of blood flow
during the procedure, it should be avoided in patients
with contralateral carotid artery stenosis or occlusion,
or when the collateral blood supply through the circle
of Willis is deemed inadequate. On the other hand, the
filters allow antegrade blood flow during the procedure;
they are not contraindicated even in patients with
contralateral carotid artery occlusion. Nevertheless, due
to their higher crossing profile (>3 F), the filters may
not be indicated in those tight or angulated lesions or
tortuous blood vessels because forceful passage of the
device itself through the stenosis may cause significant
local disruption to the plaque, which may in turn, induce
dissection or distal embolization.
With the favorable results of distal protection,10-14
the use of distal protection devices has become a routine,
wherever feasible, during carotid angioplasty at the
author's institution. From August 2000 to January 2002,
13 patients underwent carotid angioplasty at our
institution with distal protection. The age of the patients
ranged from 52-79 years (mean 69.3±8.8 years). The
reference internal carotid artery diameters, lesion length,
pre-procedural stenosis and residual stenosis were
3.15-6.0 mm (mean 4.07±0.87 mm), 10-35mm (mean
20.3±7.5 mm), 70-99% (mean 88.7 ± 9.9%) and 0-30%
(mean 11.2 ±12.5%) respectively. PercuSurge
GuardWire Plus system was used in 8 patients,
Angioguard filter was used in 2 patients, NeuroShield
filter was used in 2 patients and EPI filter wire was
used in 1 patient. All procedures were successful with
no peri-operative neurological event. No pre-dilatation
was needed in all cases with the GuardWire system and
the GuardWire was able to cross the lesion at the first
attempt in all cases. In the case using the EPI filter wire,
in view of the kinking morphology of the lesion, predilatation of lesion was done before it was crossed with
the filter. In other cases using the filters, no predilatation was done. The mean balloon occlusion time
in the cases using the GuardWire system was 10.2
minutes. In those patients undergoing the distal
protection of the GuardWire Plus system, one patient
could not tolerate the distal protection balloon occlusion
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and early deflation of the occlusion balloon was needed.
Another patient suffered from acute stent thrombosis,
which was successfully treated with abciximab. No perioperative neurological event was observed. At 30 days
after the procedures, no neurological event or procedure
related death was observed. No local injury to the distal
vessel was observed apart from some reversible local
spasm in three cases (one with Angioguard, one with
NeuroShield and one with GuardWire Plus system). In
all cases, macroscopically visible debris was retrieved
from the protective devices, but the amount was only
mild in all cases.
Although the distal protection devices have
undergone repeated improvement and miniaturization,
the ideal device is yet to be developed. We are still
waiting for a device that has the best characteristics of
the currently available systems, i.e. having the low
profile of the distal occlusion balloon while allowing
continuous blood flow as in the filters. While proper
selection of patients and matching of the devices to
different lesions would minimize the distal embolization
phenomenon, no current distal protection device may
safely protect, for example, a long, irregular and
angulated 99% stenosis with contralateral carotid
occlusion. Though effective in preventing distal
embolization, distal protective devices are costly and
are marketed at the price of the stents. Although further
studies on the health-economics of these devices are
needed before we can draw any conclusion on their costeffectiveness, the decrease in the incidence of major
stroke during carotid angioplasty as shown in many
published series might already make their cost justified.
In conclusion, distal embolization is the most
important complication of carotid angioplasty. Distal
protection devices have been shown to reduce the distal
embolization phenomenon. Although the ideal
protection device is yet to be developed, the currently
available protective devices appear to be useful adjunct
in carotid angioplasty.
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